Phyton Biotech COVID-19 Update
Phyton Biotech is committed to the health and safety of our employees first, and minimizing any interruptions so we can reliably supply our Active Pharmaceutical Ingredients.
Phyton Biotech’s Vice-President, Sales & Marketing Interviewed by SpeakPharma
Phyton Biotech’s Vice-President, Sales & Marketing, Jackie Labbe was delighted to speak with SpeakPharma recently about Phyton Biotech.
Phyton Biotech® Launches New Video on its Specialty Fermentation Solutions
Watch the video now to learn more about Plant Cell Fermentation Technology®
Phyton Biotech Receives Patent for the Production of Ingenol-3-angelate, Using Plant Cell Fermentation (PCF®)
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.
Phyton Biotech Partners with PellePharm to Develop Renewable Supply of Cyclopamine for Investigational Topical Cancer Therapy
Phyton Biotech partners with PellePharm.





